Long Wu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 7
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management 4
- Molecular Biology top 10%
- RNA modifications and cancer 6
- Circular RNAs in diseases 5
-
- Atrial Fibrillation Management and Outcomes 6
-
- Nanoplatforms for cancer theranostics 4
- Journals
- Scientific Reports (2 papers)International Journal of Cardiology (2 papers)World Journal of Surgery (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Long Wu
47 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 531
- Hepatology 120
- Internal Medicine 56
- Molecular Biology 842
- Cardiology and Cardiovascular Medicine 277
Countries citing papers authored by Long Wu
This map shows the geographic impact of Long Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Wu more than expected).
Fields of papers citing papers by Long Wu
This network shows the impact of papers produced by Long Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Wu. The network helps show where Long Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Long Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 19 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 4 | |
| 6 | 2020 | 76 | |
| 7 | 2020 | 9 | |
| 8 | 2020 | 11 | |
| 9 | 2020 | 185 | |
| 10 | 2018 | 64 | |
| 11 | 2018 | 29 | |
| 12 | 2017 | 9 | |
| 13 | 2017 | 46 | |
| 14 | 2016 | 62 | |
| 15 | 2015 | 37 | |
| 16 | 2015 | 86 | |
| 17 | 2015 | 22 | |
| 18 | 2015 | 21 | |
| 19 | 2014 | 31 | |
| 20 | 2009 | 33 |
About Long Wu
Long Wu is a scholar working on Internal Medicine, Cancer Research and Hepatology, having authored 50 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers), Atrial Fibrillation Management and Outcomes (6 papers), RNA modifications and cancer (6 papers), Circular RNAs in diseases (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). The work is most often cited by research in Cancer Research (531 citations), Hepatology (120 citations) and Internal Medicine (56 citations). Long Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yafei Li, Na Wu, Ying Xiang, Yufeng Yuan, Li Zhong, Zhisu Liu, Tian Lan, Xiangyu Ma, Zhiyuan Song and Ganggang Wang. Their work appears in journals such as Scientific Reports, International Journal of Cardiology, World Journal of Surgery, Canadian Journal of Cardiology and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.